These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 19413549)

  • 1. A review of anticoagulation intensity and outcomes among patients prescribed oral anticoagulant therapy: a systematic review and meta-analysis.
    Pickett F; Gurenlian JR
    Int J Dent Hyg; 2009 May; 7(2):151-2. PubMed ID: 19413549
    [No Abstract]   [Full Text] [Related]  

  • 2. Vitamin K to reverse the anticoagulant effect of vitamin K antagonists: can you teach an old dog new tricks?
    Douketis JD; Spyropoulos AC
    J Thromb Haemost; 2010 Mar; 8(3):496-8. PubMed ID: 20040039
    [No Abstract]   [Full Text] [Related]  

  • 3. Self-control of long-term oral anticoagulation using a point-of-care device.
    Roudaut R
    Arch Cardiovasc Dis; 2008; 101(11-12):683-4. PubMed ID: 19059561
    [No Abstract]   [Full Text] [Related]  

  • 4. A comparison of anticoagulation results of patients managed with narrow vs. standard international normalized ratio target ranges.
    Meier DJ; Seva S; Fay WP
    J Thromb Haemost; 2007 Jun; 5(6):1332-4. PubMed ID: 17403091
    [No Abstract]   [Full Text] [Related]  

  • 5. Selection and assessment of patients treated with the novel oral anticoagulant drugs: a recommendation from the Subcommittee on Control of Anticoagulation of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis.
    Ageno W; Crowther M; Baglin T; Falanga A; Buller H; Palareti G;
    J Thromb Haemost; 2013 Jan; 11(1):177-9. PubMed ID: 23419049
    [No Abstract]   [Full Text] [Related]  

  • 6. Management of oral anticoagulant treatment in patients with venous thromboembolism.
    Pengo V
    Semin Thromb Hemost; 2006 Nov; 32(8):781-6. PubMed ID: 17171590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incorporating Comprehensive Management of Direct Oral Anticoagulants into Anticoagulation Clinics.
    Mohammad I; Korkis B; Garwood CL
    Pharmacotherapy; 2017 Oct; 37(10):1284-1297. PubMed ID: 28730690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quick reference guide to the new oral anticoagulants.
    Hurst K; Lee R; Handa A
    J Vasc Surg; 2016 Jun; 63(6):1653-7. PubMed ID: 27113315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. D-dimer to guide the intensity of anticoagulation in Chinese patients after mechanical heart valve replacement: a randomized controlled trial.
    Zhang L; Zheng X; Long Y; Wu M; Chen Y; Yang J; Liu Z; Zhang Z
    J Thromb Haemost; 2017 Oct; 15(10):1934-1941. PubMed ID: 28762606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonvitamin K antagonist oral anticoagulants (NOACs): the tide continues to come in.
    Blann A
    Vasc Health Risk Manag; 2015; 11():489-92. PubMed ID: 26316773
    [No Abstract]   [Full Text] [Related]  

  • 11. Anticoagulation intensity and outcomes among patients prescribed oral anticoagulant therapy: a systematic review and meta-analysis.
    Oake N; Jennings A; Forster AJ; Fergusson D; Doucette S; van Walraven C
    CMAJ; 2008 Jul; 179(3):235-44. PubMed ID: 18663203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Native prothrombin as an alternative to prothrombin time determination for monitoring oral anticoagulant therapy.
    Pfäfflin A
    Clin Chem Lab Med; 2009; 47(2):242-3. PubMed ID: 19191733
    [No Abstract]   [Full Text] [Related]  

  • 13. The evolution of oral anticoagulant therapy.
    Dittus C; Ansell J
    Prim Care; 2013 Mar; 40(1):109-34. PubMed ID: 23402464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticoagulant drugs: what is new?
    Kei A; Florentin M; Elisaf M; Liberopoulos E
    Int Angiol; 2011 Aug; 30(4):299-320. PubMed ID: 21747349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticoagulation: managing adverse events in patients receiving anticoagulation and perioperative care.
    Hawes EM; Viera AJ
    FP Essent; 2014 Jul; 422():31-9; quiz 40-3. PubMed ID: 25033004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Recommended use of INR in the laboratory monitoring of oral anticoagulant treatment].
    Syrjälä M
    Duodecim; 1998; 114(6):573-5. PubMed ID: 11466922
    [No Abstract]   [Full Text] [Related]  

  • 17. [Oral anticoagulation therapy].
    Virjo I; Isokoski M
    Duodecim; 1998; 114(15):1518-9. PubMed ID: 11552241
    [No Abstract]   [Full Text] [Related]  

  • 18. Oral anticoagulant initiation: rationale for the use of warfarin dosing nomograms.
    Crowther MA
    Semin Vasc Med; 2003 Aug; 3(3):255-60. PubMed ID: 15199458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Periprocedural management of anticoagulation in patients taking novel oral anticoagulants: Review of the literature and recommendations for specific populations and procedures.
    Mar PL; Familtsev D; Ezekowitz MD; Lakkireddy D; Gopinathannair R
    Int J Cardiol; 2016 Jan; 202():578-85. PubMed ID: 26447666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of anticoagulation intensity and management of bleeding with old and new oral anticoagulants.
    Liew A; Eikelboom JW; O'Donnell M; Hart RG
    Can J Cardiol; 2013 Jul; 29(7 Suppl):S34-44. PubMed ID: 23790596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.